MAPT and Alzheimer disease: However, a recent study investigating PPA patients with discordant amyloid status (i.e., nfvPPA with AD pathology) has suggested that most of these cases actually present mixed pathology (FTD tau pathology as primary pathologic diagnosis and AD pathology as contributing pathologic diagnosis) (68).